Brent Burger

Superiority of Oxaliplatin and Fluorouracil-Leucovorin Compared With Either Therapy Alone in Patients With Progressive Colorectal Cancer After Irinotecan and Fluorouracil-Leucovorin: Interim Results of a Phase III Trial

Mace L. Rothenberg, Amit M. Oza, Robert Bigelow et al. · Journal of Clinical Oncology · 2003 · 645 citations

Medicine, Oncology, Pharmacology +17

Randomized Multicenter Phase II Trial of Bolus Plus Infusional Fluorouracil/Leucovorin Compared With Fluorouracil/Leucovorin Plus Oxaliplatin As Third-Line Treatment of Patients With Advanced Colorectal Cancer

Nancy E. Kemeny, Carlos A. Garay, Jayne Gurtler et al. · Journal of Clinical Oncology · 2004 · 73 citations · Full text

Medicine, Oncology, Pharmacotherapy +14

Treatment of Low-grade Intermediate-risk Nonmuscle-invasive Bladder Cancer With UGN-102 ± Transurethral Resection of Bladder Tumor Compared to Transurethral Resection of Bladder Tumor Monotherapy: A Randomized, Controlled, Phase 3 Trial (ATLAS)

Sandip M. Prasad, William C. Huang, Neal D. Shore et al. · The Journal of Urology · 2023 · 44 citations · Full text

Medicine, Surgery, Urology +10

Primary Chemoablation of Recurrent Low-Grade Intermediate-Risk Nonmuscle-Invasive Bladder Cancer With UGN-102: A Single-Arm, Open-Label, Phase 3 Trial (ENVISION)

Sandip M. Prasad, Dimitar Shishkov, Nikola V. Mihaylov et al. · The Journal of Urology · 2024 · 34 citations · Full text

Medicine, Oncology, Urology +12